Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice article, 3dt.
Imagine ..... if Sigma could get just 1% of that 100B by 2020.
Katter,
Found this for "O-VAX"
https://www.clinicaltrials.gov/ct2/show/NCT00660101?term=AVAX&rank=3
Completion Date - October 2014
And
This for M-VAX
https://www.clinicaltrials.gov/ct2/show/NCT00477906?term=NCT00477906&rank=1
Completion Date - Jan. 2015
How relevant this is to today.....?????
Definately Heavy shorting end of day. Probably the same one(s) that popped the price to .025. It's the up tick rule.
I personally don't expect to hear much of anything until December. Unless of course there is news from the earlier trial. Someone mentioned there is a time limit on trials reporting?? Can you fill us in on that?
HAHAHAHAHA!!!
I see someone is bound and determined to collapse the SP. At 11:43:04 someone dropped the SP, FROM .0159 TO .0151 with a sell of one (1) share.
Thank's Sab,
I found it..... and yes it's really, really ugly.
That was then - this is now.
CTCA must have some faith in the O-VAX / M-VAX process or they wouldn't have settled. The would have told AVAX to just keep paying up.
Question. Someone said something to the effect of the retail shares getting crushed - as opposed to the preferred shares. Can you explain?
I've learned to never count my chickens--- on"ANY" stock. But I feel .25 to .40 in the near(2 to 6 months) term is not unreasonable.
After all, CTCA was bending AVXT over table for a dry hump (forgive the analogy). Then all of a sudden they came up with the "new" deal. To me..... that says they saw something they liked and aren't worried about the price of their new preferred shares tanking. And Firebird transferred all the debt that AVAX owed them to preferred shares as well. They must know something we don't. After all they have a lot of medical experts at their disposal.
Hey 3dPrintinvestor,
When is Graphine3d going to put out financials?
That Graphene Pr is nice. But what about financials. No financials = Stinky Pinky.
Sorry, but G3d has had lots of time to get financials ready. If they can put out a Pr that states they have this big name client and that big name client and "claim" to have made 1M+ - then put out the financials to show it. Otherwise ----- it's Stinky Pinky Land for G3d.
Morning Z
How about this RFB goody. @ STOCKGOODIES
Post #1995429.
"$SGLB - COLLAPSE IMMINENT
A Short play of a lifetime. Easily flip for over 50% profit on the downside. Has fallen through support and MMs not putting in support or filling the gaps. Already gapped down 10-12%."
And yes it's "on topic" since it deals with SGLB.
No idea. Everything in stocks is a crap shoot. (my opinion) Would like to see a POP to .25+. But it would take a great PR, especially if connected to Trials and FDA.
I've heard some say as high as .40 - but who knows?
I should also note. If there is a substantial good news announcement-----you better have your shares locked and loaded----'cause it will POP hard and fast.
Just my opinion
Until there is a new announcement you should expect some volatility. Shorter's will always be around, unless like in China they are outlawed. Brings back the old adage of if you don't like a stock ... don't buy it and you own it and things change that you don't like ... sell. None of this crap of borrowing stocks then manipulating them to drop."Causes GOOD companies to go belly up before they even get a chance to start." You can blame your SEC for being so lazy and crooked (and possibly on the take) they don't even police it anymore unless it's a HIGH PROFILE stock.
How do you think a lot of these DAY TRADERS make their money. Buy when cheap and as the stock rises sell the shares then Borrow shares to short and start a negative campaign to get them to drop - making money going both ways - Rinse and repeat.
For now I'm holding - may pick up more at these prices and will wait to see if there is a further announcement.
GLTY
Looks like an MM beat down. Shorting Btards. + Trust me there were day trader/shorter's involved as well.
Shorting
Morning Z,
Just rooting out a snake from under a rock. Sigma Labs has proven products, proven contacts and contracts starting to materialize (no pun intended).
PS: Thank's DAD, Nice news about upcoming events. Haven't looked at my E-mail yet (still got my head on crooked after the Jays win!!!!).
GLTA
GR1D,
Nice post and thank you.
Hey, your back. Hows that investigation going you had set out against Sigma Labs? Any word back yet? Just curious. After all you told everyone on the board you were going to have a Gov. investigation brought on against Sigma Labs. And since it's pertinent and "On Topic" about Sigma Labs, I thought I'd ask.
I knew that:) Just proving he's a liar.
Excuse me Goldmind. Can you show me via news releases and PR's where SGLB isn't making progress and is diluting shares. I'm curious to know where you might be getting your information so that I may look it up for myself. I try to keep up on Sigma's events and haven't found this out YET.
That last trade was someone trying to shake the tree or trigger stop losses. 500 shares at .071
It wasn't the 250K sell that did it - that only dropped the price a fraction. It was the little twit shorter or someone trying to drop the price that did the damage today.
5K sell - price went from .026 to .0211.
5000 X .0049 = $24.50 minus fees. = McDonalds tonight!!!!!!!!!!!!!!!!!!
Dumb twit.
I knew that. It's all in the "double footlong extrapolators".:))))
Not a bad day at all folks. We hit .03 and had an up day. AND we still have a 96% strong buy rating.
"WHEN" GE and HONEYWELL announce multiple purchases of Printrite systems, they won't have far to go for a big party!!!!!:)
Shorting at it's finest!
From .03 to .0291 - 25K sell. A $22.50 trade - fees of course.
That's not Shak'n the tree to get cheap shares folks.
Rookie,
Someone posting is a major antagonist. Goes from board to board (check his/her posts) saying what a rotten co. that company is. And then reports people that challenge him/her.
Don't fall into the trap of replying.
Go AVXT. CTCA and Firebird AND the FDA can't be wrong.
$.03's coming soon.
What a POS:(
What a POS:(
Just my 2 cents,
In the prevailing months AVAX is poised to introduce new Phase studies of it's ground breaking Melanoma and Ovarian cancer treatments.
CTCA is a known cancer treatment center and Firebird a major money funder.
Both of these companies (lets face it) are in the business of making money from the services they provide. Neither one in my opinion are in the business of losing money. CTCA and Firebird have "accepted" preferred shares worth $5 / share in leu of debt or judgments.
In this respect there are probably time restrictions in place as to the selling of these shares and if there isn't they aren't going to sell as long as the retail price sits around 3 cents.
AVAX now is trying to procure funding for the continuation of clinical trials. So far results are very promising on what they have done so far. Avax is or has been in talks with the FDA for continuing clinical trials on M-VAX and O-VAX "AND" has received approval for trial continuations. Right now AVAX is in the process of finalizing clinical trial results information for submittal to the FDA, and this should be completed shortly.
Is everything in life a crap shoot? You bet. But as I see it (see, there is my 2 cents) neither of these companies are going to place their bets on a losing cancer treatment. Results are promising and as long as AVAX pulls up their socks, keeps a web site open AND updated, put out PR's of pertinant information for investors to see this could be a major winner.
Now for my 4 cents - BUY.
Truth,
I love that word--- ....."committed".....
From the AVAX WEBSITE
"AVAX's Phase III Study
AVAX plans to launch an International Phase III Registration trial with its lead product MVax® by the end of the year. The Phase III study will enroll approximately 400 patients. AVAX has met with the United States Food and Drug Administration ("FDA") on the study design and has plans to continue to work with FDA to be able to focus and re-launch this pivotal clinical study.
The protocol will be based on published data showing that administration of MVax® alone can induce clinically meaningful anti-tumor responses in patients with stage III and IV melanoma."
"SCAM ALERT"!!!!!! STRONG SELL!!!!!
Thank's Jax.
When do they plan on reporting?
+31% up now- .088
"Scam Alert"